T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$1.76B |
| 2 |
Eli Lilly
LLY
|
+$1.4B |
| 3 |
Bank of America
BAC
|
+$1.3B |
| 4 |
Tesla
TSLA
|
+$1.19B |
| 5 |
Wells Fargo
WFC
|
+$784M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$6.47B |
| 2 |
Amazon
AMZN
|
+$3.71B |
| 3 |
Yum! Brands
YUM
|
+$2.84B |
| 4 |
Salesforce
CRM
|
+$2.77B |
| 5 |
Fortive
FTV
|
+$2.41B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.06% |
| 2 | Healthcare | 18.72% |
| 3 | Consumer Discretionary | 14.62% |
| 4 | Financials | 10.36% |
| 5 | Communication Services | 9.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2251
Coursera
COUR
$1.53B
| $386K | ﹤0.01% |
35,804
+2,343
| +7% | +$31.1K |
|
2252
Recursion Pharmaceuticals
RXRX
$1.78B
| $386K | ﹤0.01% |
36,206
+13,406
| +59% | +$136K |
|
2253
American Well
AMWL
$220M
| $385K | ﹤0.01% |
5,360
+2,241
| +72% | +$196K |
|
2254
Stewart Information Services
STC
$2.07B
| $385K | ﹤0.01% |
8,810
+1,753
| +25% | +$89.5K |
|
|
SHCR
2255
DELISTED
Sharecare, Inc. Class A Common Stock
SHCR
| $385K | ﹤0.01% |
202,144
+71,087
| +54% | +$125K |
|
2256
Veeco
VECO
$3.28B
| $384K | ﹤0.01% |
20,941
+3,694
| +21% | +$75.6K |
|
2257
Standex International
SXI
$3.97B
| $383K | ﹤0.01% |
4,689
+1,347
| +40% | +$120K |
|
2258
8x8 Inc
EGHT
$303M
| $380K | ﹤0.01% |
109,872
+42,663
| +63% | +$204K |
|
2259
Precigen
PGEN
$2.32B
| $379K | ﹤0.01% |
178,734
+68,110
| +62% | +$144K |
|
|
TWOU
2260
DELISTED
2U Inc
TWOU
| $379K | ﹤0.01% |
2,017
+21
| +1% | +$5.47K |
|
2261
Talos Energy
TALO
$2.58B
| $378K | ﹤0.01% |
22,669
+4,358
| +24% | +$78.1K |
|
|
AGEN
2262
Agenus
AGEN
$315M
| $377K | ﹤0.01% |
9,349
+1,040
| +13% | +$53K |
|
2263
MYR Group
MYRG
$5.1B
| $376K | ﹤0.01% |
4,429
+1,024
| +30% | +$93.8K |
|
2264
NRC Health Common Stock
NRC
$471M
| $376K | ﹤0.01% |
9,425
+847
| +10% | +$31.4K |
|
|
UMH
2265
UMH Properties
UMH
$1.42B
| $376K | ﹤0.01% |
23,249
-643,430
| -97% | -$12.1M |
|
2266
Rio Tinto
RIO
$160B
| $375K | ﹤0.01% |
6,804
| – | – |
|
|
BAND
2267
Bandwidth Inc
BAND
$1.74B
| $372K | ﹤0.01% |
31,198
+15,913
| +104% | +$261K |
|
2268
Clover Health Investments
CLOV
$2.38B
| $371K | ﹤0.01% |
217,934
+81,834
| +60% | +$214K |
|
|
JAMF
2269
DELISTED
Jamf
JAMF
| $371K | ﹤0.01% |
16,699
+4,857
| +41% | +$120K |
|
|
TA
2270
DELISTED
TravelCenters of America LLC
TA
| $371K | ﹤0.01% |
+6,870
| New | +$342K |
|
2271
Lightwave Logic
LWLG
$1.12B
| $370K | ﹤0.01% |
50,322
+21,757
| +76% | +$204K |
|
|
ARR
2272
Armour Residential REIT
ARR
$2.37B
| $369K | ﹤0.01% |
15,133
+4,995
| +49% | +$175K |
|
|
GOOD
2273
Gladstone Commercial Corp
GOOD
$641M
| $368K | ﹤0.01% |
23,705
+3,107
| +15% | +$59.2K |
|
2274
Keros Therapeutics
KROS
$211M
| $367K | ﹤0.01% |
+9,730
| New | +$337K |
|
2275
FuboTV Inc
FUBO
$296M
| $366K | ﹤0.01% |
8,571
+2,021
| +31% | +$86.8K |
|
Similar funds
T. Rowe Price Associates's Q3 2022 Portfolio in Review
As of Q3 2022, T. Rowe Price Associates held 3,114 positions worth $610B, down 23% from $791B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
T. Rowe Price Associates withdrew a net $168B in Q3 2022, closing 171 positions and reducing 1,248 holdings. Its most notable exit was Alcon, an estimated $1.51B position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, T. Rowe Price Associates opened a new position in Corebridge Financial worth $194M.
- T. Rowe Price Associates's largest Q3 2022 buy was Corebridge Financial: 9,831,688 shares worth $194M.
- T. Rowe Price Associates added most to ExxonMobil in Q3 2022, an estimated $1.76B increase.
- T. Rowe Price Associates's biggest Q3 2022 reduction was Microsoft, cutting an estimated $6.47B.
- T. Rowe Price Associates fully exited Alcon in Q3 2022, selling an estimated $1.51B.
- T. Rowe Price Associates's ten largest holdings make up 31% of its $610B portfolio in Q3 2022.
- T. Rowe Price Associates opened 154 new positions and closed 171 in Q3 2022.
- T. Rowe Price Associates's portfolio value fell 23% quarter-over-quarter to $610B.
Based on T. Rowe Price Associates's 13F filing for Q3 2022, filed 14 Nov 2022.